We have added new and updated SBA and EMQ questions on Pregnancy and Breast Cancer , based on the recently updated RCOG Green Top Guideline No. 12, to our MRCOG Part 2 Revision Question Bank . Test your knowledge with these free sample questions!
0 of 2 Questions completed
Questions:
You have already completed the quiz before. Hence you can not start it again.
You must sign in or sign up to start the quiz.
You must first complete the following:
Quiz complete. Results are being recorded.
Time has elapsed
Categories
MRCOG Part 2 – Maternal Medicine
0%
Question 1 of 2
A 29-year-old nulliparous woman presents to her GP at 16 weeks of gestation, after noticing a painless lump in her left breast for the past 3 weeks. She has no nipple discharge or skin changes. There is no personal or family history of breast or ovarian cancer. She does not smoke or drink alcohol. On examination, there is a 3 cm firm, irregular, non-tender lump in the upper outer quadrant of the left breast. The overlying skin appears normal. One palpable, mobile axillary lymph node is noted. The contralateral breast is normal. What is the most appropriate next investigation?
Question 2 of 2
For each scenario described below, choose the most causative treatment:
A 30-year-old woman, Gravida 2 Para 1, is diagnosed at 22 weeks of gestation with a 4 cm invasive ductal carcinoma of the right breast. Histology confirms triple-negative breast cancer (ER-negative, PR-negative, HER2-negative). She is managed by the multidisciplinary team and undergoes a mastectomy at 24 weeks gestation. From 26 weeks onwards, she receives anthracycline and cyclophosphamide chemotherapy with carboplatin plus weekly paclitaxel, as recommended for triple-negative disease in pregnancy. During her chemotherapy treatment, she has significant difficulties with nausea and vomiting and receives corticosteroids and and NK-1 antagonists to mitigate this. She is noted to have significant glycosuria and blood glucose capillary monitoring shows levels all above 9.0mmol.
0 of 2 Questions completed
Questions:
You have already completed the quiz before. Hence you can not start it again.
You must sign in or sign up to start the quiz.
You must first complete the following:
Quiz complete. Results are being recorded.
Time has elapsed
Categories
MRCOG Part 2 - Maternal Medicine
0%
Question 1 of 2
A 29-year-old nulliparous woman presents to her GP at 16 weeks of gestation, after noticing a painless lump in her left breast for the past 3 weeks. She has no nipple discharge or skin changes. There is no personal or family history of breast or ovarian cancer. She does not smoke or drink alcohol. On examination, there is a 3 cm firm, irregular, non-tender lump in the upper outer quadrant of the left breast. The overlying skin appears normal. One palpable, mobile axillary lymph node is noted. The contralateral breast is normal. What is the most appropriate next investigation?
Question 2 of 2
For each scenario described below, choose the most causative treatment:
A 30-year-old woman, Gravida 2 Para 1, is diagnosed at 22 weeks of gestation with a 4 cm invasive ductal carcinoma of the right breast. Histology confirms triple-negative breast cancer (ER-negative, PR-negative, HER2-negative). She is managed by the multidisciplinary team and undergoes a mastectomy at 24 weeks gestation. From 26 weeks onwards, she receives anthracycline and cyclophosphamide chemotherapy with carboplatin plus weekly paclitaxel, as recommended for triple-negative disease in pregnancy. During her chemotherapy treatment, she has significant difficulties with nausea and vomiting and receives corticosteroids and and NK-1 antagonists to mitigate this. She is noted to have significant glycosuria and blood glucose capillary monitoring shows levels all above 9.0mmol.
